SUPERNUS PHARMACEUTICALS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for SUPERNUS PHARMACEUTICALS NOTE 0.625% 4/0, CUSIP 868459AD0.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for SUPERNUS PHARMACEUTICALS NOTE 0.625% 4/0, CUSIP 868459AD0.